Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cresud is a leading Argentine agribusiness company with over 80 years of history, focused on the production of grains (soybean, corn, wheat), oilseeds, sugarcane, and beef cattle across Argentina and South America. It also holds significant interests in farmland real estate and operates through subsidiaries such as BrasilAgro in Brazil and IRSA in Argentine real estate[1][5][8]. The company has demonstrated resilience despite commodity price fluctuations and regional economic challenges[6][8]. In FY2025 Q3 (ending March 31, 2025), it reported a profit of ARS 57.9 billion with strong agricultural output—planting about 300k hectares regionally for an expected yield of ~867k tons of grains—and robust cattle activity[8]. It continues to expand its agribusiness model regionally. Notably not a life science/biotech/pharma/healthcare company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cresud.